L Barreto

522 total citations
15 papers, 409 citations indexed

About

L Barreto is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, L Barreto has authored 15 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Microbiology, 7 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in L Barreto's work include Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). L Barreto is often cited by papers focused on Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). L Barreto collaborates with scholars based in Canada, United States and Sweden. L Barreto's co-authors include William Meekison, Roland Guasparini, Francisco Noya, David W. Scheifele, Elaine L. Mills, Marina Ulanova, W. Paul Glezen, Janet A. Englund, Michael G. Bruce and Marcus Lem and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

L Barreto

15 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Barreto Canada 10 332 309 87 49 45 15 409
Tatsuo Aoyama Japan 11 418 1.3× 375 1.2× 115 1.3× 34 0.7× 62 1.4× 30 501
Kati Edelman Finland 9 254 0.8× 306 1.0× 96 1.1× 24 0.5× 55 1.2× 9 359
Catherine H. Bozio United States 10 222 0.7× 291 0.9× 77 0.9× 74 1.5× 23 0.5× 22 466
M.A. Witt United States 6 283 0.9× 298 1.0× 71 0.8× 50 1.0× 48 1.1× 15 393
A. Bourillon France 6 330 1.0× 342 1.1× 52 0.6× 124 2.5× 16 0.4× 12 454
Raïssa Nadège Caboré Belgium 7 347 1.0× 365 1.2× 90 1.0× 141 2.9× 9 0.2× 8 441
Leslie H. Wetterlow United States 7 249 0.8× 247 0.8× 41 0.5× 28 0.6× 17 0.4× 8 319
Véronique Abitbol France 12 274 0.8× 291 0.9× 32 0.4× 67 1.4× 10 0.2× 17 363
Ehab Bassily United States 8 202 0.6× 281 0.9× 97 1.1× 27 0.6× 11 0.2× 9 321
Shelly Senders United States 12 204 0.6× 345 1.1× 79 0.9× 62 1.3× 4 0.1× 25 409

Countries citing papers authored by L Barreto

Since Specialization
Citations

This map shows the geographic impact of L Barreto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Barreto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Barreto more than expected).

Fields of papers citing papers by L Barreto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Barreto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Barreto. The network helps show where L Barreto may publish in the future.

Co-authorship network of co-authors of L Barreto

This figure shows the co-authorship network connecting the top 25 collaborators of L Barreto. A scholar is included among the top collaborators of L Barreto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Barreto. L Barreto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Janaudis‐Ferreira, Tania, Marla Beauchamp, Jean Bourbeau, et al.. (2024). Virtual Rehabilitation for Individuals With Long COVID: A Randomized Controlled Trial. A2761–A2761. 2 indexed citations
2.
Cox, Andrew D., et al.. (2017). Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop. Canada Communicable Disease Report. 43(5). 89–95. 16 indexed citations
3.
Tsang, Raymond S. W., Michael G. Bruce, Marcus Lem, L Barreto, & Marina Ulanova. (2014). A review of invasiveHaemophilus influenzaedisease in the Indigenous populations of North America. Epidemiology and Infection. 142(7). 1344–1354. 42 indexed citations
4.
5.
6.
7.
Barreto, L, et al.. (2005). Conquering the Crippler: Canada and the eradication of polio (Insert). 96(2). 1–24. 1 indexed citations
8.
Olin, P, Hans O. Hallander, Lea Nørgreen Gustafsson, L Barreto, & Audino Podda. (1998). Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination.. PubMed. 95. 211–20. 9 indexed citations
9.
10.
11.
Scheifele, David W., et al.. (1993). Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?. PubMed. 149(8). 1105–12. 31 indexed citations
12.
Barreto, L, et al.. (1992). Evaluation of clinical data in bladder cancer immunotherapy with Connaught BCG (ImmuCyst).. PubMed. 77. 229–31. 2 indexed citations
13.
Englund, Janet A., W. Paul Glezen, & L Barreto. (1992). Controlled Study of aNew Five-Component Acellular Pertussis Vaccine in Adults and Young Children. The Journal of Infectious Diseases. 166(6). 1436–1441. 31 indexed citations
14.
Sparkes, John D., et al.. (1992). Stability of BCG vaccine (intravesical) Theracys/BCG therapeutic ImmuCyst and its importance in clinical efficacy.. PubMed. 77. 217–22. 2 indexed citations
15.
Scheifele, David W., et al.. (1991). Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.. PubMed. 145(6). 641–7. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuo Aoyama Breakdown of academic impact, for papers by Kati Edelman Breakdown of academic impact, for papers by Catherine H. Bozio Breakdown of academic impact, for papers by M.A. Witt Breakdown of academic impact, for papers by A. Bourillon Breakdown of academic impact, for papers by Raïssa Nadège Caboré Breakdown of academic impact, for papers by Leslie H. Wetterlow Breakdown of academic impact, for papers by Véronique Abitbol Breakdown of academic impact, for papers by Ehab Bassily Breakdown of academic impact, for papers by Shelly Senders
Rankless by CCL
2026